Works matching IS 08876924 AND DT 2010 AND VI 24 AND IP 11

Results: 23

OCT-1 activity measurement provides a superior imatinib response predictor than screening for single-nucleotide polymorphisms of OCT-1.

Published in:

2010

By:

White, D. L.;
Saunders, V. A.;
Dang, P.;
Engler, J.;
Hughes, T. P.

Publication type:

Letter

High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias.

Published in:

2010

By:

Morisot, S.;
Wayne, A. S.;
Bohana-Kashtan, O.;
Kaplan, I. M.;
Gocke, C. D.;
Hildreth, R.;
Stetler-Stevenson, M.;
Walker, R. L.;
Davis, S.;
Meltzer, P. S.;
Wheelan, S. J.;
Brown, P.;
Jones, R. J.;
Shultz, L. D.;
Civin, C. I.

Publication type:

journal article

Mixed-phenotype acute leukemia: historical overview and a new definition.

Published in:

Leukemia (08876924), 2010, v. 24, n. 11, p. 1844, doi. 10.1038/leu.2010.202

By:

Weinberg, O. K.;
Arber, D. A.

Publication type:

Article

A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL.

Published in:

2010

By:

Brown, J. R.;
Abramson, J.;
Hochberg, E.;
Mikler, E.;
Dalton, V.;
Werner, L.;
Reynolds, H.;
Thompson, C.;
McDonough, S. M.;
Kuang, Y.;
Ritz, J.;
Neuberg, D.;
Freedman, A. S.

Publication type:

clinical trial

Efficacy of the association of lenalidomide to erythropoiesis-stimulating agents in del (5q) MDS patients refractory to single-agent lenalidomide.

Published in:

2010

By:

Park, S.;
Vassilieff, D.;
Bardet, V.;
Viguié, F.;
Dreyfus, F.

Publication type:

Letter

The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation.

Published in:

Leukemia (08876924), 2010, v. 24, n. 11, p. 1852, doi. 10.1038/leu.2010.187

By:

Thepot, S.;
Zhou, J.;
Perrot, A.;
Robin, M.;
Xhaard, A.;
de Latour, R. P.;
Ades, L.;
Ribaud, P.;
Petropoulou, A. D.;
Porcher, R.;
Socié, G.

Publication type:

Article

Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138(+) cells.

Published in:

2010

By:

Colla, S.;
Storti, P.;
Donofrio, G.;
Todoerti, K.;
Bolzoni, M.;
Lazzaretti, M.;
Abeltino, M.;
Ippolito, L.;
Neri, A.;
Ribatti, D.;
Rizzoli, V.;
Martella, E.;
Giuliani, N.

Publication type:

Letter

Gfi1 and Gfi1b: key regulators of hematopoiesis.

Published in:

Leukemia (08876924), 2010, v. 24, n. 11, p. 1834, doi. 10.1038/leu.2010.195

By:

van der Meer, L. T.;
Jansen, J. H.;
van der Reijden, B. A.

Publication type:

Article

B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells.

Published in:

Leukemia (08876924), 2010, v. 24, n. 11, p. 1885, doi. 10.1038/leu.2010.176

By:

Gross, E.;
L.'Faqihi-Olive, F.-E.;
Ysebaert, L.;
Brassac, M.;
Struski, S.;
Kheirallah, S.;
Fournié, J.-J.;
Laurent, G.;
Quillet-Mary, A.

Publication type:

Article

Comment on 'Integrative genomic profiling of human prostate cancer'.

Published in:

2010

By:

Bullinger, L.;
Krönke, J.;
Gaidzik, V.;
Döhner, H.;
Döhner, K.

Publication type:

Letter

Overexpression of survivin initiates hematologic malignancies in vivo.

Published in:

2010

By:

Small, S.;
Keerthivasan, G.;
Huang, Z.;
Gurbuxani, S.;
Crispino, J. D.

Publication type:

journal article

A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154.

Published in:

2010

By:

Wierda, W. G.;
Castro, J. E.;
Aguillon, R.;
Sampath, D.;
Jalayer, A.;
McMannis, J.;
Prussak, C. E.;
Keating, M.;
Kipps, T. J.

Publication type:

journal article

Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif.

Published in:

Leukemia (08876924), 2010, v. 24, n. 11, p. 1901, doi. 10.1038/leu.2010.186

By:

Abrahamsen, I. W.;
Stronen, E.;
Wälchli, S.;
Johansen, J. N.;
Kjellevoll, S.;
Kumari, S.;
Komada, M.;
Gaudernack, G.;
Tjonnfjord, G.;
Toebes, M.;
Schumacher, T. N.;
Lund-Johansen, F.;
Olweus, J.

Publication type:

Article

Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping.

Published in:

2010

By:

Costa, E. S.;
Pedreira, C. E.;
Barrena, S.;
Lecrevisse, Q.;
Flores, J.;
Quijano, S.;
Almeida, J.;
del Carmen García- Macias, M.;
Bottcher, S.;
Van Dongen, J. J. M.;
Orfao, A.;
del Carmen García-Macias, M

Publication type:

journal article

High frequencies of simultaneous FLT3-ITD, WT1 and KIT mutations in hematological malignancies with NUP98-fusion genes.

Published in:

2010

By:

Taketani, T.;
Taki, T.;
Nakamura, T.;
Kobayashi, Y.;
Ito, E.;
Fukuda, S.;
Yamaguchi, S.;
Hayashi, Y.

Publication type:

Letter

Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM).

Published in:

2010

By:

Lacy, M. Q.;
Hayman, S. R.;
Gertz, M. A.;
Short, K. D.;
Dispenzieri, A.;
Kumar, S.;
Greipp, P. R.;
Lust, J. A.;
Russell, S. J.;
Dingli, D.;
Zeldenrust, S.;
Fonseca, R.;
Bergsagel, P. L.;
Roy, V.;
Mikhael, J. R.;
Stewart, A. K.;
Laumann, K.;
Allred, J. B.;
Mandrekar, S. J.;
Rajkumar, S. V.

Publication type:

journal article

Insights into the stem cells of chronic myeloid leukemia.

Published in:

Leukemia (08876924), 2010, v. 24, n. 11, p. 1823, doi. 10.1038/leu.2010.159

By:

Sloma, I.;
Jiang, X.;
Eaves, A. C.;
Eaves, C. J.

Publication type:

Article

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire.

Published in:

Leukemia (08876924), 2010, v. 24, n. 11, p. 1867, doi. 10.1038/leu.2010.200

By:

Mohty, M.;
Labopin, M.;
Balère, M. L.;
Socié, G.;
Milpied, N.;
Tabrizi, R.;
Ifrah, N.;
Hicheri, Y.;
Dhedin, N.;
Michallet, M.;
Buzyn, A.;
Cahn, J.-Y.;
Bourhis, J.-H.;
Blaise, D.;
Raffoux, C.;
Espérou, H.;
Yakoub-Agha, I.

Publication type:

Article

Acute myeloid leukemia cells fail to activate native human dendritic cells: a potential mechanism of immune evasion.

Published in:

2010

By:

Wehner, R.;
Schumacher, P.;
Bornhäuser, M.;
Ehninger, G.;
Schäkel, K.;
Bachmann, M.;
Schmitz, M.

Publication type:

Letter

DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.

Published in:

Leukemia (08876924), 2010, v. 24, n. 11, p. 1951, doi. 10.1038/leu.2010.196

By:

Joseph-Pietras, D.;
Gao, Y.;
Zojer, N.;
Ait-Tahar, K.;
Banham, A. H.;
Pulford, K.;
Rice, J.;
Savelyeva, N.;
Sahota, S. S.

Publication type:

Article

Identification of disease- and therapy-associated proteome changes in the sera of patients with myelodysplastic syndromes and del(5q).

Published in:

Leukemia (08876924), 2010, v. 24, n. 11, p. 1875, doi. 10.1038/leu.2010.182

By:

Chen, C.;
Bowen, D. T.;
Giagounidis, A. A. N.;
Schlegelberger, B.;
Haase, S.;
Wright, E. G.

Publication type:

Article

Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation.

Published in:

2010

By:

Sprynski, A. C.;
Hose, D.;
Kassambara, A.;
Vincent, L.;
Jourdan, M.;
Rossi, J. F.;
Goldschmidt, H.;
Klein, B.

Publication type:

journal article

The t(6;9) associated DEK/CAN fusion protein targets a population of long-term repopulating hematopoietic stem cells for leukemogenic transformation.

Published in:

Leukemia (08876924), 2010, v. 24, n. 11, p. 1910, doi. 10.1038/leu.2010.180

By:

Oancea, C.;
Rüster, B.;
Henschler, R.;
Puccetti, E.;
Ruthardt, M.

Publication type:

Article